Cargando…

Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal

Detalles Bibliográficos
Autores principales:	Lippi, Giuseppe, Plebani, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682048/ https://www.ncbi.nlm.nih.gov/pubmed/36443132 http://dx.doi.org/10.1016/j.ejim.2022.11.025

Ejemplares similares

SARS-CoV-2 antibodies titration: a reappraisal
por: Lippi, Giuseppe, et al.
Publicado: (2020)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Cellular immunity against SARS-CoV-2 depends on the serological status
por: Pighi, Laura, et al.
Publicado: (2023)

Repeated Testing in SARS-CoV-2 Infection
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Serological testing for SARS-CoV-2: Advancements and future challenges
por: Alexopoulos, Harry, et al.
Publicado: (2023)

Exposure history and molecular epidemiology of SARS-CoV-2: A reappraisal
por: Joob, Beuy, et al.
Publicado: (2023)

Defining laboratory medicine: a circle cannot be squared
por: Lippi, Giuseppe, et al.
Publicado: (2021)

LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Anti-SARS-CoV-2 Antibodies Testing in Recipients of COVID-19 Vaccination: Why, When, and How?
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal
por: Lippi, Giuseppe, et al.
Publicado: (2022)

SARS-CoV-2 RT-PCR test, false result problem, public risk assessment and reliability of epidemiology statistics
por: Joob, Beuy, et al.
Publicado: (2020)

Possible drawbacks of relying only on molecular testing for diagnosing SARS-CoV-2 infections
por: Lippi, G., et al.
Publicado: (2022)

COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

SARS-CoV-2 IGM and IGG rapid serologic test for the diagnosis of COVID-19 in the emergency department
por: Cancella de Abreu, Marta, et al.
Publicado: (2020)

Is diffusion of SARS-CoV-2 variants of concern associated with different symptoms?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Qualitative serology in patients recovered from SARS CoV 2 infection
por: Bettencourt, Paulo, et al.
Publicado: (2020)

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

Clinical pearls and pitfalls of SARS-CoV-2 serology
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Lower nasopharyngeal viral load in young SARS-CoV-2-positive subjects
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants
por: Lippi, Giuseppe, et al.
Publicado: (2023)

Serological assessment is advisable before COVID-19 vaccination
por: Lippi, Giuseppe, et al.
Publicado: (2022)

A reappraisal of corticosteroids use for COVID-19
por: Pati, Ilaria, et al.
Publicado: (2022)

A Dual-Antigen SARS-CoV-2 Serological Assay Reflects Antibody Avidity
por: Nakagama, Yu, et al.
Publicado: (2022)

COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load
por: Salvagno, Gian Luca, et al.
Publicado: (2022)

Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
por: Plebani, Mario, et al.
Publicado: (2020)

Interim analysis of the clinical performance of five SARS-Cov-2 serology assays
por: Knauer, Michael J., et al.
Publicado: (2020)

Highly efficient respirators are needed for the Omicron variant of SARS-CoV-2
por: Mattiuzzi, C., et al.
Publicado: (2022)

Serological Evidence of Coxiella burnetii and SARS-CoV-2 Co-infection: A Case Report
por: Park, Hee Sue, et al.
Publicado: (2021)

Serological profile of first SARS-CoV-2 reinfection cases detected within the SIREN study
por: Atti, A., et al.
Publicado: (2022)

Analysis of online search trends suggests that SARS-CoV-2 Omicron (B.1.1.529) variant causes different symptoms
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Anti-SARS-CoV-2 IgG antibodies in patients with or without SARS-CoV-2 infection after BNT162b2 vaccine booster
por: Salvagno, G.L., et al.
Publicado: (2022)

Systematic Review of Diagnostic Accuracy of DiaSorin Liaison SARS-CoV-2 Antigen Immunoassay
por: Lippi, Giuseppe, et al.
Publicado: (2022)

IgM anti-SARS-CoV-2-specific determination: useful or confusing? Big Data analysis of a real-life scenario
por: Trenti, Tommaso, et al.
Publicado: (2021)

Has SARS-CoV-2 evolved and adapted to circulate at high temperatures?
por: Lippi, G., et al.
Publicado: (2022)

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak
por: Blairon, Laurent, et al.
Publicado: (2021)

Serological testing for SARS-CoV-2 in Bosnia and Herzegovina: first report
por: Ašić, Adna, et al.
Publicado: (2021)

Opisthorchiasis, hypercholesterolemia, and cholangiocarcinoma: A reappraisal
por: Joob, Beuy, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qrrnrngvq5pogqsng2f1ma5dr2